This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Karen M. Joos, MD, PhD; Alan E. Kimura, MD; Kimberlie Vandenburgh; James A. Bartley, MD, PhD; Edwin M. Stone, MD, PhD

Arch Ophthalmol. 1994;112(12):1574-1579.

Abstract
Objective
To diagnose the carriers and noncarriers in a family affected with Norrie disease based on molecular analysis.

Design
Family members from three generations, including one affected patient, two obligate carriers, one carrier identified with linkage analysis, one noncarrier identified with linkage analysis, and one female family member with indeterminate carrier status, were examined clinically and electrophysiologically. Linkage analysis had previously failed to determine the carrier status of one female family member in the third generation. Blood samples were screened for mutations in the Norrie disease gene with single-strand conformation polymorphism analysis. The mutation was characterized by dideoxy-termination sequencing.

Results
Ophthalmoscopy and electroretinographic examination failed to detect the carrier state. The affected individuals and carriers in this family were found to have a transition from thymidine to cytosine in the first nucleotide of codon 39 of the Norrie disease gene, causing a cysteine-to-arginine mutation. Single-strand conformation polymorphism analysis identified a patient of indeterminate status (by linkage) to be a noncarrier of Norrie disease.

Conclusion
Ophthalmoscopy and electroretinography could not identify carriers of this Norrie disease mutation. Single-strand conformation polymorphism analysis was more sensitive and specific than linkage analysis in identifying carriers in this family.

Author Affiliations
From the Department of Ophthalmology, The University of Iowa, Iowa City (Drs Joos, Kimura, and Stone and Ms Vandenburgh); The Bascom Palmer Eye Institute, University of Miami (Fla) School of Medicine (Dr Joos); and Integrated Genetics, Signal Hill, Calif (Dr Bartley).; Dr Stone is a Research to Prevent Blindness Dolly Green Scholar. Dr Joos is now with the Department of Ophthalmology and Visual Sciences, Vanderbilt University, Nashville, Tenn.

Footnotes
The authors have no financial interest in the subject matter or materials discussed in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Novel Mutations in Norrie Disease Gene in Japanese Patients with Norrie Disease and Familial Exudative Vitreoretinopathy
Kondo et al.
IOVS 2007;48:1276-1282.
ABSTRACT | FULL TEXT  

Norrie Disease: Diagnosis of a Simplex Case by DNA Analysis
Chynn et al.
Arch Ophthalmol 1996;114:1136-1138.
ABSTRACT